Clinical trial readout dates for Relay Therapeutics Inc., compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is April 2028.
Next readoutApril 2028in ~17 months
Upcoming readouts31 Phase 3
Market cap$3.5B
Cash & investments$849M~10 quarters at last loss rate
Recent 8-K filings1latest 2026-11-04
Upcoming readouts
Phase 3Zovegalisib
PIK3CA Mutation; HER2- Negative Breast Cancer · NCT06982521
Relay Therapeutics Inc. reported $849M in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-04). Its net loss for that quarter was $82M; at that rate the cash would last about 10 quarters. This is a rough guide: net loss includes non-cash items such as stock compensation, and does not count money the company may raise, so its own runway guidance can differ.
Recent SEC filings
8-KResults of Operations — earnings, may carry pipeline updates